Alnylam Pharmaceuticals SG&A Expense (TTM) Insights

Alnylam Pharmaceuticals, Inc. (ALNY)

399.83 +1.13 (+0.28%) USD | NASDAQ | Dec 24, 10:44

View SG&A Expense (TTM) for ALNY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (TTM) Benchmarks

Start Trial